This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Allergic rhinitis is characterised by rhinorrhoea, nasal blockage and sneezing attacks for longer than 1 hour per day lasting for 2 weeks.

More detailed information concerning clinical features is presented below:

  • nasal blockage—intermittent, alternating unilateral blockage—a persistent unilateral blockage may indicate a mechanical cause e.g., septum deviation, nasal polyp
  • sneezing—often paroxysmal (1)
  • nasal itching
  • rhinorrhoea—can be anterior resulting in persistent sniffing and nose-blowing, or posterior resulting in postnasal drip; if there is unilateral rhinorrhoea in an adult, this should alert the clinician to the possibility of cerebrospinal fluid
  • unilateral rhinorrhoea in a child may be secondary to a foreign body
  • epiphora, reddening of conjunctivae, swelling of eyelids
  • reduced taste or smell
  • headaches—often without sinusitis; the pain may be referred to the forehead, lateral to nose, around the eye or over the cheeks
  • reduced hearing due to eustachian tube dysfunction

Signs may include:

  • oedematous nasal mucosa, often blue
  • clear nasal discharge
  • nasal crease or nasal salute, especially in children

Reference:

  1. Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46(9):1139–51.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.